| Bioactivity | Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1]. |
| Target | Glial cell derived neurotrophic factor family receptor alpha 3 (GFRA3) |
| Name | Nadecnemab |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nadecnemab. Drugbank. |